Form 8-K - Current report:
SEC Accession No. 0001193125-25-075871
Filing Date
2025-04-08
Accepted
2025-04-08 17:09:06
Documents
14
Period of Report
2025-04-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d901769d8k.htm   iXBRL 8-K 32101
2 EX-10.1 d901769dex101.htm EX-10.1 130996
  Complete submission text file 0001193125-25-075871.txt   316521

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA jazz-20250407.xsd EX-101.SCH 2859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE jazz-20250407_lab.xml EX-101.LAB 18689
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jazz-20250407_pre.xml EX-101.PRE 11692
17 EXTRACTED XBRL INSTANCE DOCUMENT d901769d8k_htm.xml XML 3815
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 25822792
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)